Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 May;84(10):3420–3424. doi: 10.1073/pnas.84.10.3420

Purification and characterization of rat liver nuclear thyroid hormone receptors.

K Ichikawa, L J DeGroot
PMCID: PMC304882  PMID: 3472213

Abstract

Nuclear thyroid hormone receptor was purified to 904 pmol of L-3,5,3'-triiodothyronine (T3) binding capacity per mg of protein with 2.5-5.2% recovery by sequentially using hydroxylapatite column chromatography, ammonium sulfate precipitation, Sephadex G-150 gel filtration, DNA-cellulose column chromatography, DEAE-Sephadex column chromatography, and heparin-Sepharose column chromatography. Assuming that one T3 molecule binds to the 49,000-Da unit of the receptor, we reproducibly obtained 6.4-14.7 micrograms of receptor protein with 4.2-4.9% purity from 4-5 kg of rat liver. Elution of receptor from the heparin-Sepharose column was performed using 10 mM pyridoxal 5'-phosphate, which was observed to diminish binding of receptor to heparin-Sepharose or DNA-cellulose. This effect was specific for pyridoxal 5'-phosphate, since related compounds were not effective. Purified receptor bound T3 with high affinity (6.0 X 10(9) liter/mol), and the order of affinity of iodothyronine analogues to purified receptor was identical to that observed with crude receptor preparations [3,5,3'-triiodothyroacetic acid greater than L-T3 greater than D-3,5,3'-triiodothyronine (D-T3) greater than L-thyroxine greater than D-thyroxine]. Purified receptor had a sedimentation coefficient of 3.4 S, Stokes radius of 34 A, and calculated molecular mass of 49,000. Among several bands identified by silver staining after electrophoresis in NaDodSO4/polyacrylamide gels, one 49,000-Da protein showed photoaffinity labeling with [125I]thyroxine that was displaceable with excess unlabeled T3. The tryptic fragment and endogenous proteinase-digested fragment of the affinity-labeled receptor showed saturable binding in 27,000-Da and 36,000-Da peptides, respectively. These molecular masses are in agreement with estimates from gel filtration and gradient sedimentation, indicating that affinity labeling occurred at the hormone binding domain of nuclear thyroid hormone receptor. This procedure reproducibly provides classical native rat liver T3 nuclear receptor in useful quantity and purity and of the highest specific activity so far reported.

Full text

PDF
3420

Images in this article

3423Image
on p.3423
3423Image
on p.3423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apriletti J. W., Eberhardt N. L., Latham K. R., Baxter J. D. Affinity chromatography of thyroid hormone receptors. Biospecific elution from support matrices, characterization of the partially purified receptor. J Biol Chem. 1981 Dec 10;256(23):12094–12101. [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Cake M. H., DiSorbo D. M., Litwack G. Effect of pyridoxal phosphate on the DNA binding site of activated hepatic glucocorticoid receptor. J Biol Chem. 1978 Jul 25;253(14):4886–4891. [PubMed] [Google Scholar]
  4. Degroot L. J., Refetoff S., Strausser J., Barsano C. Nuclear triiodothyronine-binding protein: partial characterization and binding to chromatin. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4042–4046. doi: 10.1073/pnas.71.10.4042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  6. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  7. Latham K. R., Ring J. C., Baxter J. D. Solubilized nuclear "receptors" for thyroid hormones. Physical characteristics and binding properties, evidence for multiple forms. J Biol Chem. 1976 Dec 10;251(23):7388–7397. [PubMed] [Google Scholar]
  8. Milgrom E. Monoclonal antibodies to steroid hormone receptors. Pharmacol Ther. 1985;28(3):389–415. doi: 10.1016/0163-7258(85)90060-9. [DOI] [PubMed] [Google Scholar]
  9. Morrissey J. H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981 Nov 1;117(2):307–310. doi: 10.1016/0003-2697(81)90783-1. [DOI] [PubMed] [Google Scholar]
  10. Nikodem V. M., Cheng S. Y., Rall J. E. Affinity labeling of rat liver thyroid hormone nuclear receptor. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7064–7068. doi: 10.1073/pnas.77.12.7064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nyborg J. K., Nguyen A. P., Spindler S. R. Relationship between thyroid and glucocorticoid hormone receptor occupancy, growth hormone gene transcription, and mRNA accumulation. J Biol Chem. 1984 Oct 25;259(20):12377–12381. [PubMed] [Google Scholar]
  12. Oppenheimer J. H., Koerner D., Schwartz H. L., Surks M. I. Specific nuclear triiodothyronine binding sites in rat liver and kidney. J Clin Endocrinol Metab. 1972 Aug;35(2):330–333. doi: 10.1210/jcem-35-2-330. [DOI] [PubMed] [Google Scholar]
  13. Oppenheimer J. H., Schwartz H. L., Surks M. I. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology. 1974 Sep;95(3):897–903. doi: 10.1210/endo-95-3-897. [DOI] [PubMed] [Google Scholar]
  14. Pascual A., Casanova J., Samuels H. H. Photoaffinity labeling of thyroid hormone nuclear receptors in intact cells. J Biol Chem. 1982 Aug 25;257(16):9640–9647. [PubMed] [Google Scholar]
  15. Samuels H. H., Stanley F., Casanova J. Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells. J Clin Invest. 1979 Jun;63(6):1229–1240. doi: 10.1172/JCI109418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shupnik M. A., Ardisson L. J., Meskell M. J., Bornstein J., Ridgway E. C. Triiodothyronine (T3) regulation of thyrotropin subunit gene transcription is proportional to T3 nuclear receptor occupancy. Endocrinology. 1986 Jan;118(1):367–371. doi: 10.1210/endo-118-1-367. [DOI] [PubMed] [Google Scholar]
  17. Silva E. S., Astier H., Thakare U., Schwartz H. L., Oppenheimer J. H. Partial purification of the triiodothyronine receptor from rat liver nuclei. Differences in the chromatographic mobility of occupied and unoccupied sites. J Biol Chem. 1977 Oct 10;252(19):6799–6805. [PubMed] [Google Scholar]
  18. Surks M. I., Koerner D., Dillman W., Oppenheimer J. H. Limited capacity binding sites for L-triiodothyronine in rat liver nuclei. Localization to the chromatin and partial characterization of the L-triiodothyronine-chromatin complex. J Biol Chem. 1973 Oct 25;248(20):7066–7072. [PubMed] [Google Scholar]
  19. Torresani J., Anaelmet A. Partial purification and characterization of nuclear triiodothyronine binding proteins. Biochem Biophys Res Commun. 1978 Mar 15;81(1):147–153. doi: 10.1016/0006-291x(78)91642-x. [DOI] [PubMed] [Google Scholar]
  20. Torresani J., DeGroot L. J. Triiodothyronine binding to liver nuclear solubilized proteins in vitro. Endocrinology. 1975 May;96(5):1201–1209. doi: 10.1210/endo-96-5-1201. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES